Filing Details

Accession Number:
0001209191-21-067068
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-29 21:49:30
Reporting Period:
2021-11-24
Accepted Time:
2021-11-29 21:49:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780080 Ian Clements C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-24 700 $14.40 17,811 No 4 P Direct
Common Stock Acquisiton 2021-11-26 750 $13.90 18,561 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.